DOUGLAS JOHNSON

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology NASHVILLE, TN NPI 1154597458

General Payments — all program years on this page

$50,347.21

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 49
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $7,552.35 across 9 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
AstraZeneca UK Limited $3,425.001
Merck Sharp & Dohme Corporation $2,135.001
E.R. Squibb & Sons, L.L.C. $1,690.002
Acerta Pharma LLC $302.355

By program year

Program yearAmountRecords
2018 $7,572.3710
2019 $10,443.0314
2020 $11,043.185
2021 $4,260.003
2022 $6,853.334
2023 $2,622.954
2024 $7,552.359

Records — PY2024 (9)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1093978951 AstraZeneca UK Limited $3,425.00 03/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101233429 E.R. Squibb & Sons, L.L.C. $1,680.00 07/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101233437 E.R. Squibb & Sons, L.L.C. $10.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104227209 AstraZeneca Pharmaceuticals LP $23.94 07/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1104361607 AstraZeneca Pharmaceuticals LP $223.04 04/12/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 View at CMS
1104513428 AstraZeneca Pharmaceuticals LP $6.11 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105275966 AstraZeneca Pharmaceuticals LP $11.49 04/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1105608031 AstraZeneca Pharmaceuticals LP $37.77 06/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141674481 Merck Sharp & Dohme LLC $2,135.00 06/26/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.